Correlation Between CD133+ Stem Cells and Clinical Improvement in Patients with Autism Spectrum Disorders Treated with Intrathecal Bone Marrow-derived Mononuclear Cells.
Laura Villarreal‐Martínez(Almaz-Antey (Russia)), Laura Elia MartÍnez-Garza(Hospital Universitario Dr José Eleuterio Gonzalez), Iram P. Rodríguez‐Sánchez(Hospital Universitario Dr José Eleuterio Gonzalez), Neri Alejandro Álvarez‐Villalobos(Almaz-Antey (Russia)), Fernando Guzman-Gallardo(Almaz-Antey (Russia)), Sulia Pope-Salazar(Almaz-Antey (Russia)), Cynthia Salinas-Silva(Almaz-Antey (Russia)), Maria Guadalupe Cepeda-Cepeda(Almaz-Antey (Russia)), Alejandra Garza‐Bedolla(Almaz-Antey (Russia)), Irving Armando Dominguez-Varela(Almaz-Antey (Russia)), Daniel Zacarias Villarreal-Martinez(Almaz-Antey (Russia)), J. Humberto Treviño-Villarreal(Almaz-Antey (Russia)), David Gómez‐Almaguer(Almaz-Antey (Russia))
PubMed
January 1, 2022
Cited by 4Open Access
Abstract
=0.01; r= -0.60) posttreatment positively correlated with the enrichment of a putative BM stem cell population expressing the cluster of differentiation 133+ (CD133+) surface marker.
Related Papers
No related papers found
Powered by citation graph analysis